Cargando…
Alarmins, COVID-19 and comorbidities
The coronavirus SARS-CoV-2, the aetiological agent of COVID-19 disease, is representing a worldwide threat for the medical community and the society at large so that it is being defined as “the twenty-first-century disease”. Often associated with a severe cytokine storm, leading to more severe cases...
Autores principales: | Di Salvo, Eleonora, Di Gioacchino, Mario, Tonacci, Alessandro, Casciaro, Marco, Gangemi, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168739/ https://www.ncbi.nlm.nih.gov/pubmed/34042528 http://dx.doi.org/10.1080/07853890.2021.1921252 |
Ejemplares similares
-
Do Alarmins Have a Potential Role in Autism Spectrum Disorders Pathogenesis and Progression?
por: Di Salvo, Eleonora, et al.
Publicado: (2018) -
Role of Alarmins in the Pathogenesis of Systemic Sclerosis
por: Giovannetti, Antonello, et al.
Publicado: (2020) -
Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation
por: Imbalzano, Egidio, et al.
Publicado: (2022) -
IL-31, itch and hematological malignancies
por: Di Salvo, Eleonora, et al.
Publicado: (2021) -
IL-33 genetics and epigenetics in immune-related diseases
por: Di Salvo, Eleonora, et al.
Publicado: (2021)